by Mike Masnick
Wed, May 13th 2009 8:52am
For years, we've been among those who have questioned how the hell anyone (let alone the US Patent Office) can justify the concept of patenting genes. Yet, the Patent Office has continued to issue such patents, even as they have been shown to cause significant problems in diagnosing and treating certain illnesses. Finally, however, it appears that the concept of patenting genes is about to get tested in court. The ACLU has organized a group of cancer patients who have had treatments and medical analysis limited due to gene patents held by the company Myriad Genetics, and brought the issue to court. This is a big deal... and while the case and the resulting appeals will certainly take many years, this is going to be a case well worth watching.
If you liked this post, you may also be interested in...
- Why Patent Trolls Love East Texas... And Why Congress Needs To Fix It
- Could A Hedge Fund Manager Trying To Short Stocks Of Pharma Companies With Bad Patents Derail Patent Reform?
- Almost Everything About JDate's Lawsuit Against JSwipe Is Absurd: Trademark & Patent Insanity
- 4th Amendment Lives: Court Tells US Government Get A Warrant If It Wants Mobile Phone Location Info
- DOJ To Court: Hey, We're Shutting Down Section 215, So We Can Probably Stop Arguing About The Legality Of Bulk Collection